Ro exited compounded GLP-1s in 2026 amid FDA enforcement pressure on the category Brand-name Wegovy oral pill (FDA-approved semaglutide) $149/month first month, rising to $199$299/month at higher ongoing doses Brand-name Wegovy injection/pen (FDA-approved) $199/month first month, rising to $199$399/month ongoing Brand-name Zepbound KwikPen (FDA-approved tirzepatide) $299/month first month, rising to $399$449/month ongoing Brand-name Ozempic (FDA-approved semaglutide for type 2 diabetes) insurance-dependent pricing (not independently verified this sweep) Important compliance note on compounded products Compounded semaglutide and compounded tirzepatide whether obtained through Cora Health or other telehealth platforms that offer compounded medication are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound)
Winselow Tucker, president and general manager of Eli Lilly India : "We are an innovative company with an innovative product, and we price based on the value delivered to patients, physicians, and the healthcare system
From there, any future change is easy to spot and act on
Sitohang IBS, Anwar AI, Jusuf NK, Arimuko A, Norawati L, Veronica S.J Clin Aesthet Dermatol
This dual action is particularly powerful in supporting weight loss, as it addresses both metabolic imbalances and behavioral aspects of eating
